What race and ethnicity measure in pharmacologic research

Journal of Clinical Pharmacology

Volumn 46, Issue 4, 2006, Pages 401-404

  Doyle, Jamie Mihoko ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clinical trials; Ethnicity; FDA; Genetics; Measurement; Pharmacology; Race; Regulations

Indexed keywords

TRASTUZUMAB;

BREAST CANCER; CULTURAL ANTHROPOLOGY; DIET; DRUG ABSORPTION; DRUG METABOLISM; DRUG RESEARCH; DRUG RESPONSE; EMOTIONAL STRESS; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; HEALTH BEHAVIOR; HUMAN; IMMUNE RESPONSE; MENTAL HEALTH; MENTAL STRESS; PHARMACOGENETICS; PROTEIN EXPRESSION; RACE DIFFERENCE; REVIEW; SOCIAL CLASS; SOCIAL STATUS;

BIAS (EPIDEMIOLOGY); BIOMEDICAL RESEARCH; CONTINENTAL POPULATION GROUPS; CULTURAL CHARACTERISTICS; DIET; ENVIRONMENT; ETHNIC GROUPS; HEALTH BEHAVIOR; HUMANS; PHARMACOGENETICS; SOCIOECONOMIC FACTORS;

EID: 33644982178     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270005282633     Document Type: Review

References (45)

1. Bamshad M, Wooding S, Salisbury BA, Stephens JC. Deconstructing the relationship between genetics and race. Nat Rev Genet. 2004;5:598-602.
2. Chaturvedi N. Ethnicity as an epidemiological determinant - crudely racist or crucially important? Int J Epidemiol. 2001;30:925-927.
3. Goodman AH. Why genes don't count (for racial differences in health). Am J Public Health. 2001;90:1699-1702.
4. Reiner AP, Ziv E, Lind DL, et al. Population structure, admixture, and aging-related phenotypes in African American adults: the cardiovascular health study. Am J Hum Genet. 2005;76:463-477.
5. Nature Genetics [editorial]. Genes, drugs, and race. Nat Genet. 2001;29:265-269.
6. Wilson JF, Weale ME, Smith AC, et al. Population genetic structure of variable drug response. Nat Genet. 2001;29:265-269.
7. Young D. Scientists focus on pharmacogenomics at FDA science forum. American Journal of Health System-Pharmacy. 2005;62:1226-1228.
8. Service RF. Going from genome to pill. Science. 2005; 308:1858-1860.
9. Bullock HE, Wyche KF, Williams WR. Media images of the poor. J Soc Issues. 2001;57:229-246.
10. Gilens M. Race and poverty in America - public misperceptions and the American news media. Public Opin Q. 1996;60:515-541.
11. DeNavas-Walt C, Mills R, Procter B. Income, poverty, and health insurance coverage in the United States: 2003. U.S. Census Bureau Web site. Available at: http://www.census.gov/prod/2004pubs/p60-226.pdf.
12. Williams DR, Collins C. U.S. socioeconomic and racial differences in health: patterns and explanations. Annu Rev Sociol. 1995;21:349-386.
13. Adler NE, Boyce WT, Chesney MA, Folkman S, Syme SL. Socioeconomic inequalities in health - no easy solution. JAMA. 1993;24:3140-3145.
14. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341-378.
15. Bjornsson TD, Wagner AJ, Donahue SR, et al. A review and assessment of potential sources of ethnic differences in drug responsiveness. J Clin Pharmacol. 2003;43:943-967.
16. Frank R. The misuse of biology in demographic research on racial/ethnic differences: a reply to Van Den Oord and Rowe. Demography. 2001;38:563-567.
17. Hummer RA, Rogers RG, Eberstein IW. Sociodemographic differentials in adult mortality: a review of analytic approaches. Popul Dev Rev. 1998;24:553-578.
18. Dominick KL, Bosworth HB, Hsieh JB, Moser BK. Racial differences in analgesic/anti-inflammatory medication use and perceptions of efficacy. J Natl Med Assoc. 2004;96:928-932.
19. Yang CS, Brady JF, Hong JY. Dietary-effects on cytochomosomes-P450, xenobiotic metabolism, and toxicity. FASEB J. 1992;6:737-744.
20. Miners JO, Mackenzie PI. Drug glucuronidation in humans. Pharmacol Ther. 1991;51:347-369.
21. Kaminsky LS, Fasco MJ. Small intestinal cytochromosomes-P450. Crit Rev Toxicol. 1992;21:407-422.
22. Armstrong TL, Swartzman LC. Asian versus western differences in satisfaction with western medical care: the mediational effects of illness attributions. Psychol Health. 1999;14:403-416.
23. Evelyn B, Toigo T, Banks D, et al. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. J Natl Med Assoc. 2001;93(suppl 12):18S-24S.
24. Kagawa-Singer M. Improving the validity and generalizability of studies with underserved U.S. populations expanding the research paradigm. Ann Epidemiol. 2000;10(suppl 8):S92-S103.
25. Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol. 2000;10(suppl 8):S22-S34.
26. McEwen BS. Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. Metabolism. 2003;52(suppl 10):10-16.
27. Taylor SE, Repetti RL, Seeman T. Health psychology: what is an unhealthy environment and how does it get under the skin? Ann Rev Psychol. 1997;48:411-447.
28. Whitfield KE, Weidner G, Clark R, Anderson NB. Sociodemographic diversity and behavioral medicine. J Consult Clin Psychol. 2002;70:463-481.
29. Steffen PR, McNeilly M, Anderson N, Sherwood A. Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. Psychosom Med. 2003;65:746-750.
30. Brosschot JF, Thayer JF. Anger inhibition, cardiovascular recovery, and vagal function: a model of the link between hostility and cardiovascular disease. Ann Behav Med. 1998;20:326-332.
31. Waldstein SR, Burns HO, Toth MJ, Poehlman ET. Cardiovascular reactivity and central adiposity in older African Americans. Health Psychol. 1999;18:221-228.
32. Geronimus AT, Bound J, Waidmann TA, Colen CG, Steffick D. Inequality in life expectancy, functional status, and active life expectancy across selected black and white populations in the United States. Demography. 2001;38:227-251.
33. Hayward MD, Heron M. Racial inequality in active life among adult Americans. Demography. 1999;36:77-91.
34. Coutinho R, David RJ, Collins JW. Relation of parental birth weights to infant birth weight among African Americans and whites in Illinois: a transgenerational study. Am J Epidemiol. 1997;146:804-809.
35. Schoendorf KC, Hogue CJR, Kleinman JC, Rowley D. Mortality among infants of black as compared with white college-educated parents. N Engl J Med. 1992;326:1522-1526.
36. Krieger N. Embodying inequality: a review of concepts, measures, and methods for studying health consequences of discrimination. Int J Health Serv. 1999;29:295-352.
37. Buka SL, Brennan RT, Rich-Edwards JW, Raudenbush SW, Earls F. Neighborhood support and the birth weight of urban infants. Am J Epidemiol. 2003;157:1-8.
38. Morenoff JD. Neighborhood mechanisms and the spatial dynamics of birth weight. Am J Sociol 2003;108:976-1017.
39. Yen IH, Syme SL. The social environment and health: a discussion of the epidemiologic literature. Annu Rev Public Health. 1999;20:287-308.
40. Lwebuga-Mukasa JS, Oyana TJ, Wydro P. Risk factors for asthma prevalence and chronic respiratory illnesses among residents of different neighborhoods in Buffalo, New York. J Epidemiol Community Health.2004;58:951-957.
41. Aligne CA, Auinger P, Byrd RS, Weitzman M. Risk factors for pediatric asthma: contributions of poverty, race, and urban residence. Am J Resp Crit Care Med.2000;162(pt 1):873-877.
42. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med.2001;344:783-792.
43. Code of Federal Regulations. Title 21, Vol. 5. U.S. Food and Drug Administration Web site. Available at: http://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=314.50&SearchTerm=racial. Accessed September 16, 2005.
44. U.S. Department of Health and Human Services. Guidance for industry collection of race and ethnicity data in clinical trials. Fed Regist. 2003;68.
45. Clinical Data Interchange Standards Consortium, Submission Data Standards (CDISC SDS). Comments on draft guidance for industry: collection of race and ethnicity data in clinical trials. Division of Dockets Management. Available at: http://www.fda.gov/ohrms/dockets/dockets/02d0018/02D-0018-emc00004-01.pdf. Accessed September 16, 2005).